SMS Life Sciences India gets DSIR recognition for Hyderabad R&D unit
The said registration is valid upto March 31, 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian pharma market expected to grow to $130 bn by 2030: Gowda
India is being applauded globally in its fight against COVID, development of seven more vaccines is in pipeline: Mansukh Mandaviya
US FDA makes five observations after Alembic Pharma facility inspection
Alembic Pharma informed that “none of the observations are related to data integrity and are procedural in nature”
Clinical Data Standards in the era of AI, ML and digital transformation
Shrishaila Patil, VP, Statistical Programming, Navitas Data Sciences, a part of Navitas Life Sciences (a TAKE Solutions…
Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData
Deal value decreased by 89 per cent in Jan 2021, compared to Dec 2020
India set to meet world’s 70 per cent COVID-19 vaccine needs: Amit Shah
He also said that 55 lakh people in the country have been given COVID-19 vaccine in the last 21 days and the Centre is working to…
UK says COVID-19 booster and annual vaccinations very probable
A COVID-19 booster in the autumn and then annual vaccinations are very probable, Britain's vaccine deployment minister said on…
Sun Pharma recalls 36,275 cartons of testosterone injection in the US for labelling error
As per the US FDA, a class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not…
Third Phase will begin in march and covers ages 50 and above: Harsh Vardhan
On Friday, Health Minister Harsh Vardhan said in the Lok Sabha that the third phase of the vaccination drive is likely to begin in…
India asks states to speed up COVID-19 vaccination
India's government urged states and union territories on Saturday to accelerate COVID-19 vaccinations after a review found…